The Ontario Hereditary Cancer Research Network

The Ontario Hereditary Cancer Research Network Connecting Ontarians with a hereditary cancer risk to researchers, clinical trials, and other meaningful resources. Learn more at www.ohcrn.ca.

OHCRN cannot give medical advice. If you have health concerns, please consult a health care provider. We’re the Ontario Hereditary Cancer Research Network (OHCRN), a province-wide registry empowering people with a genetic risk for cancer to contribute to research. We also connect participants to clinical trials, advocacy groups, and other supportive resources.

Tamara Braid, Genetic Counsellor and Clinical Program Manager at OHCRN, recently joined the Food for Thought event hoste...
06/18/2026

Tamara Braid, Genetic Counsellor and Clinical Program Manager at OHCRN, recently joined the Food for Thought event hosted by the Canadian VHL Alliance (Canadian VHL Alliance). There, she talked about the cancer risks linked to VHL and the ways that research can advance care.
Von Hippel–Lindau (VHL) disease is a rare genetic condition that increases the risk of developing tumours, cysts, and cancer in different parts of the body.
It was so nice to connect with such a passionate community dedicated to advancing care and support for those with VHL.
Learn more about the CVHLA at cvhla.ca.

This Pride Month, OHCRN recognizes that hereditary cancer care isn't one-size-fits-all. A recent study by Roth et al. hi...
06/16/2026

This Pride Month, OHCRN recognizes that hereditary cancer care isn't one-size-fits-all. A recent study by Roth et al. highlights how 2SLGBTQIA+ individuals navigating inherited cancer risk face gaps in care because it was not designed with them in mind. Inclusive language, shared decision-making and affirming care can make a big difference. Read more here: https://pubmed.ncbi.nlm.nih.gov/38342966/

Can we vaccinate against cancer? Listen to the head of OHCRN, Dr. Raymond Kim, discuss exciting advances in cancer preve...
06/12/2026

Can we vaccinate against cancer? Listen to the head of OHCRN, Dr. Raymond Kim, discuss exciting advances in cancer prevention! He is featured in OICR's "Ask a Cancer Researcher" series.
https://bit.ly/3QBgS3u

Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.

May 22 is NF2-related schwannomatosis (NF2) awareness day! Did you know, NF2 is a genetic condition caused by a mutation...
05/22/2026

May 22 is NF2-related schwannomatosis (NF2) awareness day! Did you know, NF2 is a genetic condition caused by a mutation in the NF2 gene (on chromosome 22!).
People with NF2 often have tumours (schwannomas and meningiomas) that can cause dizziness and hearing loss.
On Saturday, May 16, OHCRN Clinical Program Manager/Genetic Counsellor Tamara joined the other with Neurofibromatosis Society of Ontario (NFON) at Toronto City Hall to raise awareness.

Today is Neurofibromatosis type 1 (NF1) awareness day. Did you know? Individuals with NF1 have an increased chance of de...
05/17/2026

Today is Neurofibromatosis type 1 (NF1) awareness day. Did you know? Individuals with NF1 have an increased chance of developing cancer (like breast cancer or a rare type of gastrointestinal tumour called a GIST*).
Last month, OHCRN Clinical Program Manager/Genetic Counsellor Tamara spoke at the Neurofibromatosis Society of Ontario (NFON) Forum and officially become a ! Check out NFON by visiting https://nfon.ca.

*Reference: https://bit.ly/3Ptuux3

05/14/2026

Grateful to the Ontario Institute for Cancer Research (OICR, https://oicr.on.ca) for shining a spotlight on OHCRN!
Cancer research takes many forms across OICR, but the goal is always the same: improving the lives of people affected by cancer. For those with hereditary cancer, that journey can come with unique and complex challenges.
Watch the first OICR Impact Minute to learn how and why OHCRN was created, and how we’re working to advance research that makes a difference.

May is Von Hippel-Lindau (VHL) awareness month! We'd like to highlight the Canadian VHL Alliance (CVHLA), a non-profit s...
05/11/2026

May is Von Hippel-Lindau (VHL) awareness month! We'd like to highlight the Canadian VHL Alliance (CVHLA), a non-profit supporting individuals and families with VHL. Learn more at https://cvhla.ca.
On June 6, OHCRN Clinical Program Manager Tamara will be attending CVHLA's 1st Food for Thought event at La Plume in Toronto.
If you or someone you know has VHL and would like to join us for lunch and conversation, you can register here: https://bit.ly/4ewbAjn.

Today is World Ovarian Cancer Day. Up to 25% of all ovarian cancer is caused by an inherited gene change*. You may have ...
05/08/2026

Today is World Ovarian Cancer Day. Up to 25% of all ovarian cancer is caused by an inherited gene change*. You may have heard of genes like BRCA1 and BRCA2, but other genes can increase risk of ovarian cancer as well, like MSH2, BRIP1, RAD51C, and RAD51D.
*Reference: Ovarian Cancer Canada (check out their good work!)

This website uses cookies to ensure you have the best user experience. By continuing to use this website, you consent to our use of cookies. For more information, read our privacy policy.

Address

MaRS Centre, 661 University Avenue, Suite 510
Toronto, ON
M5G0A3

Alerts

Be the first to know and let us send you an email when The Ontario Hereditary Cancer Research Network posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share